Prestige SVP sells 1,207 shares at $54.99

Prestige Consumer Healthcare Senior VP Operations Jeffrey Zerillo reported an open-market sale of 1,207 shares of common stock at $54.99 per share.

Rhea-AI Filing Summary

Prestige Consumer Healthcare Senior VP Operations Jeffrey Zerillo reported an open-market sale of 1,207 shares of common stock at $54.99 per share. In a separate transaction, 307 shares were disposed of to satisfy tax withholding obligations at $55.75 per share. Following these transactions, he directly holds 44,027 shares after the tax-withholding disposition and 42,820 shares after the open-market sale, indicating these trades involved a relatively small portion of his reported direct holdings.

Insider Trade Summary

Net Seller: 1,207 shares

Net Sell 2 txns

Insider Zerillo Jeffrey

Role Senior VP Operations

Sold 1,207 shs ($66K)

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock, par value $0.01 per share	307	$55.75	$17K
Sale	Common Stock, par value $0.01 per share	1,207	$54.99	$66K

Holdings After Transaction: Common Stock, par value $0.01 per share — 42,820 shares (Direct)

Key Figures

Open-market shares sold: 1,207 shares Sale price: $54.99/share Tax-withholding shares: 307 shares +4 more

7 metrics

Open-market shares sold 1,207 shares Non-derivative open-market sale on transaction date

Sale price $54.99/share Price for 1,207-share open-market sale

Tax-withholding shares 307 shares Non-derivative F-coded tax-withholding disposition

Tax-withholding price $55.75/share Price for 307-share tax-withholding disposition

Shares after tax disposition 44,027 shares Direct holdings following F-coded transaction

Shares after open-market sale 42,820 shares Direct holdings following S-coded sale

Net shares sold 1,207 shares Net buy/sell shares from transaction summary

Key Terms

open-market sale, tax-withholding disposition, non-derivative, Form 4

4 terms

open-market sale financial

"reported an open-market sale of 1,207 shares of common stock"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

tax-withholding disposition financial

"307 shares were disposed of to satisfy tax withholding obligations"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

non-derivative financial

"This sale was reported as a non-derivative transaction coded as an open-market"

Form 4 regulatory

"The Form 4 shows a tax-withholding disposition of 307 Prestige Consumer shares"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Prestige Consumer (PBH) report for Jeffrey Zerillo?

Prestige Consumer reported that Senior VP Operations Jeffrey Zerillo sold 1,207 common shares in an open-market transaction and disposed of 307 additional shares for tax withholding. Both transactions involved directly held stock and were reported on the same transaction date.

How many Prestige Consumer (PBH) shares did Jeffrey Zerillo sell and at what price?

Jeffrey Zerillo sold 1,207 shares of Prestige Consumer common stock in an open-market transaction at a price of $54.99 per share. This sale was reported as a non-derivative transaction coded as an open-market or private sale.

What is the tax-withholding disposition in Jeffrey Zerillo’s PBH Form 4?

The Form 4 shows a tax-withholding disposition of 307 Prestige Consumer shares at $55.75 per share. This F-coded transaction reflects shares delivered to satisfy tax liabilities, not an open-market sale, and is categorized as a non-derivative disposition.

How many Prestige Consumer (PBH) shares does Jeffrey Zerillo hold after these transactions?

After the tax-withholding disposition, Zerillo directly held 44,027 Prestige Consumer shares, and after the open-market sale, his direct holdings were 42,820 shares. These figures show his remaining position following the reported non-derivative transactions.

Are Jeffrey Zerillo’s PBH transactions open-market sales or something else?

The Form 4 reports one open-market sale of 1,207 Prestige Consumer shares, coded S, and one F-coded tax-withholding disposition of 307 shares. Only the S-coded transaction represents an open-market sale; the F-coded transaction covers tax obligations using shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/07/2026 - 04:02 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zerillo Jeffrey

(Last) (First) (Middle)

660 WHITE PLAINS ROAD

(Street)

TARRYTOWN NEW YORK 10591

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Prestige Consumer Healthcare Inc. [ PBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior VP Operations

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.01 per share	05/05/2026		F		307	D	$55.75	44,027	D
Common Stock, par value $0.01 per share	05/05/2026		S		1,207	D	$54.99	42,820	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jeffrey Zerillo by William P'Pool as attorney-in-fact pursuant to power of attorney dated August 7, 2018 on file with the Commission	05/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)